Extended-spectrum β-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria
Open Access
- 1 August 2004
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 10 (8), 752-755
- https://doi.org/10.1111/j.1469-0691.2004.00929.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Detection of CTX-M-15 extended-spectrum -lactamase in the United KingdomJournal of Antimicrobial Chemotherapy, 2003
- First description of CTX-M-15-producing Klebsiella pneumoniae in TurkeyJournal of Antimicrobial Chemotherapy, 2003
- Effect of D240G substitution in a novel ESBL CTX-M-27Journal of Antimicrobial Chemotherapy, 2003
- First isolation of CTX-M15-producing Escherichia coli from two French patients.Journal of Antimicrobial Chemotherapy, 2003
- Ceftazidime-hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in PolandJournal of Antimicrobial Chemotherapy, 2002
- CTX-M-Type Extended-Spectrum β-Lactamase That Hydrolyzes Ceftazidime through a Single Amino Acid Substitution in the Omega LoopAntimicrobial Agents and Chemotherapy, 2001
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Novel Cefotaximase (CTX-M-16) with Increased Catalytic Efficiency Due to Substitution Asp-240→GlyAntimicrobial Agents and Chemotherapy, 2001
- A new plasmidic cefotaximase in a clinical isolate of Escherichia coliInfection, 1990
- The Use of Analytical Isoelectric Focusing for Detection and Identification of -LactamasesJournal of General Microbiology, 1975